EMA Authorised: Pomalidomide Zentiva (Pomalidomide) — Zentiva, k.s.

View source ↗

Summary

Pomalidomide Zentiva has been authorised for use in multiple myeloma by the EMA; it represents a generic version of pomalidomide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide Zentiva (Pomalidomide)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: Zentiva, k.s.. Decision date: 12/05/2025